Clinical Trial Update: A Phase 2b Trial of EPB-348 for the Treatment of Herpes Zoster [Phase 2]

View source ↗

Summary

Phase 2b trial of EPB-348 for herpes zoster has completed; the update does not provide efficacy results in the excerpt.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• EPB-348

Snippet

Sponsor: Epiphany Biosciences | Conditions: Herpes Zoster | Phase 2 | Status: COMPLETED